Analyst Reco. UCB SA OTC Markets

Equities

Market Closed - OTC Markets Other stock markets 20:54:15 17/05/2024 BST			5-day change	1st Jan Change
67.62 ^USD	+2.70%		+2.24%	+55.09%

04-11	Berenberg Reiterates UCB's Purchase Rating, Raises PT	MT
04-11	UCB : Berenberg, Buy, raises its price target	CF

Berenberg Reiterates UCB's Purchase Rating, Raises PT	04-11	MT
UCB : Berenberg, Buy, raises its price target	04-11	CF
UCB : UCB all set to reach new highs	03-08
UCB : H2 beat; the prospects remain encouraging	02-28
UCB : H1 surpassed expectations, Bimzelx’s US approval much-awaited in Q3	31/07/23
UCB : Turnaround delayed but hope remains intact	20/03/23
UCB : Exceeded 2022 expectations; promising prospects, despite muted 2023 guidance	22/02/23
Berenberg European Conference	04/12/22	FA
BNPP Exane Conference - Fireside Chat	22/11/22	FA
Roche’s Alzheimer’s failure has sector-wide implications	14/11/22
UCB : Decent H1 overshadowed by future uncertainties	02/08/22
Investor Meeting - Berenberg	20/03/22	FA
UCB : 2021 results: a major confidence reinforcing event	25/02/22
Berenberg European Conference	05/12/21	FA
ANALYST RECOMMENDATIONS : Chevron, Cisco, Dollar Tree, The Gap, Salesforce...	24/11/21
ANALYST RECOMMENDATIONS : Activision Blizzard, Beyond Meat, Britvic, Las Vegas Sans, Unilever...	16/09/21
ANALYST RECOMMENDATIONS : AstraZeneca, Designer Brands, Homeserve, Rio Tinto, Trane Technologies...	02/09/21
UCB : Pricing & pandemic concerns impede upward revision to full-year outlook, despite strong H1	02/08/21
ANALYST RECOMMENDATIONS : Baidu, Canopy Growth, General Motors, Laredo Petroleum, Rolls-Royce...	09/07/21
Roadshow - Exane BNPP	05/04/21	FA

No results for this search

UCB : UCB all set to reach new highs

March 08, 2024 at 04:10 pm